BR112012033476A2 - método para a produção de proteínas autólogas - Google Patents

método para a produção de proteínas autólogas

Info

Publication number
BR112012033476A2
BR112012033476A2 BR112012033476A BR112012033476A BR112012033476A2 BR 112012033476 A2 BR112012033476 A2 BR 112012033476A2 BR 112012033476 A BR112012033476 A BR 112012033476A BR 112012033476 A BR112012033476 A BR 112012033476A BR 112012033476 A2 BR112012033476 A2 BR 112012033476A2
Authority
BR
Brazil
Prior art keywords
production
autologous proteins
autologous
proteins
Prior art date
Application number
BR112012033476A
Other languages
English (en)
Inventor
Ulrich Schneider
Original Assignee
Arthrogen Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arthrogen Gmbh filed Critical Arthrogen Gmbh
Publication of BR112012033476A2 publication Critical patent/BR112012033476A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5437—IL-13
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Analytical Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
BR112012033476A 2010-07-07 2011-06-21 método para a produção de proteínas autólogas BR112012033476A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102010026500A DE102010026500A1 (de) 2010-07-07 2010-07-07 Verfahren zur Herstellung von autologen Proteinen
PCT/DE2011/001322 WO2012010128A2 (de) 2010-07-07 2011-06-21 Verfahren zur herstellung von autologen proteinen

Publications (1)

Publication Number Publication Date
BR112012033476A2 true BR112012033476A2 (pt) 2016-10-25

Family

ID=44735759

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012033476A BR112012033476A2 (pt) 2010-07-07 2011-06-21 método para a produção de proteínas autólogas

Country Status (13)

Country Link
US (1) US9200050B2 (pt)
EP (1) EP2590659B1 (pt)
JP (1) JP6094761B2 (pt)
KR (1) KR20130139837A (pt)
CN (1) CN103037873A (pt)
AU (1) AU2011282056B2 (pt)
BR (1) BR112012033476A2 (pt)
CA (1) CA2803941A1 (pt)
DE (1) DE102010026500A1 (pt)
ES (1) ES2658269T3 (pt)
MX (1) MX353734B (pt)
RU (1) RU2013104404A (pt)
WO (1) WO2012010128A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7063885B2 (ja) 2016-09-13 2022-05-09 ザ ジャクソン ラボラトリー 標的にされた増大するｄｎａ脱メチル化

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT411901B (de) 1997-08-16 2004-07-26 Orthogen Gentechnologie Gmbh Verfahren zur induktion von therapeutisch wirksamen proteinen durch inkubation einer körperflüssigkeit in einer einen induktor enthaltenden spritze
US20030108612A1 (en) * 2001-10-31 2003-06-12 Xu Xiaohong Nancy Metallic nanoparticles for inhibition of bacterium growth
US8198094B2 (en) * 2006-03-15 2012-06-12 The Brigham And Women's Hospital, Inc. Methods of using gelsolin levels to characterize a subject's risk of developing rheumatoid arthritis
ES2651619T3 (es) * 2006-03-15 2018-01-29 The Brigham And Women's Hospital, Inc. Uso de gelsolina para tratar esclerosis múltiple y diagnosticar enfermedades neurológicas

Also Published As

Publication number Publication date
EP2590659B1 (de) 2017-11-08
WO2012010128A3 (de) 2012-05-31
AU2011282056B2 (en) 2015-02-26
CA2803941A1 (en) 2012-01-26
MX2013000072A (es) 2013-05-17
US9200050B2 (en) 2015-12-01
RU2013104404A (ru) 2014-08-20
ES2658269T3 (es) 2018-03-09
AU2011282056A1 (en) 2013-01-24
EP2590659A2 (de) 2013-05-15
JP2013537516A (ja) 2013-10-03
CN103037873A (zh) 2013-04-10
US20130323200A1 (en) 2013-12-05
DE102010026500A1 (de) 2012-01-12
MX353734B (es) 2018-01-26
KR20130139837A (ko) 2013-12-23
WO2012010128A2 (de) 2012-01-26
JP6094761B2 (ja) 2017-03-15

Similar Documents

Publication Publication Date Title
CY2019040I1 (el) Aνti-il-23 αντισωματα
CO7020849A2 (es) Microorganismo recombinante para la producción de metabolitos utiles
CO6930351A2 (es) Línea de proceso para la producción de particulas criodesecadas
BR112013012801A2 (pt) método para a produção de um calçado e calçado
BR112013031209A2 (pt) método para produção de hidrógéis
CO6930352A2 (es) Línea de proceso para la producción de partículas criodesecadas
BR112013011426A2 (pt) método para purificação de material lipídico
BR112012020964A2 (pt) método de produção de imunoglobulina
BR112014012414A2 (pt) processo para a preparação de 5-flúor-1h-pirazolopiridinas substituídas
BR112013030423A2 (pt) método para produção de biocoque
DK2564397T3 (da) Isotop-produktionsfremgangsmåde
BR112012029866A2 (pt) método para a determinação da presença de uma proteína steap-1
BR112013008883A2 (pt) processo para a fabricação de di-hidropteridinonas
BR112013009567A2 (pt) método de produção de hidrocarbonetos
BR112012021070A2 (pt) método para produção de cadaverina
BR112013006230A2 (pt) processo para a preparação de uma n-fenilhidroxilamina substituída
BR112013014949A2 (pt) processo para produção de proteína
ES2641042T8 (es) Procedimiento para la fabricación de un fármaco proteínico
FI20105633A0 (fi) Parannettu menetelmä proteiinien tuottamiseksi
BR112014006861A2 (pt) método para a coprodução de um produto de alquilbenzeno e um biocombustível
BR112013017831A2 (pt) método para a preparação de ácido nicotínico
BR112012025490A2 (pt) ''método para produção de 1,5 oebtanodiamina''
BRPI1010841A2 (pt) método para a fabricação de fluoroalquilnitrilas
BR112013014581A2 (pt) método para a fabricação de um diorgano-di-halossilano
BR112013012096A2 (pt) método para a purifação de misturas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements